Comprehensive Management Program for Lipid Disorders
If you have been diagnosed with a lipid disorder, a condition in which you have high levels of LDL (low-density lipoproteins) and triglycerides, you may be at an increased risk of heart disease. Lipid disorders can contribute to hardening of arteries, lower blood flow and poor circulation. If left untreated, lipid disorders may result in coronary heart disease (CHD), heart attack and stroke.
From high cholesterol to difficult-to-treat lipid disorders requiring complex therapy, the multidisciplinary team in Loyola Medicine’s lipid assessment and prevention program partners with you and your referring physician to develop a lipid management treatment plan that’s right for you. We collaborate with your cardiologist or primary care physician to complete advanced diagnostic testing, including plasmapheresis and risk assessment.
Working together, our goal is to prevent and slow down the way in which lipids harden the walls of your arteries and cause plaque build-up (atherosclerosis). In addition, if you have a diagnosed heart condition, your near relatives may be screened, assessed and proactively managed if they are found to have a lipoprotein disorder.
If you have high cholesterol and other lipid and lipoprotein disorders, or if you are at high risk, the following health recommendations may be introduced:
- Cholesterol-lowering medication
- Dietary changes
- Lifestyle changes
If you are concerned about your risk of developing heart disease as a result of a lipid disorder, if your disorder is resistant to therapy or if you would like information on lipid management, contact your primary care physician or cardiologist to discuss your concerns and how to partner with Loyola in your diagnosis and care.
Why Choose Loyola for Lipid Management?
Loyola offers a team of cardiologists who are also board-certified by the American Board of Clinical Lipidology, providing them with unique expertise in advanced cholesterol and lipid management. In addition, Loyola is one of few centers in the Chicago area to offer plasmapheresis, which provides complex analysis of blood and helps to define cardiac risk.